Ally Bridge Group »

Minerva Neurosciences shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Minerva Neurosciences (NERV) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Minerva Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Minerva Neurosciences held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Minerva Neurosciences by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.7M 1.7M 4.02

More positions owned by Ally Bridge Group

Replimune Group Call Option (REPL)
Edgewise Therapeutics (EWTX)
Abivax Sa Sponsored Ads (ABVX)
Soleno Therapeutics (SLNO)
Compass Pathways Sponsored Ads Call Option (CMPS)
Atai Beckley Nv SHS
Inventiva Sa Ads (IVA)
Minerva Neurosciences Com New (NERV)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Ovid Therapeutics (OVID)
Solid Biosciences Com New (SLDB)
Aadi Bioscience (WHWK)

View all positions for Ally Bridge Group

Top funds holding Minerva Neurosciences

Logos Global Management
Ally Bridge Group
Federated Investors
Vanguard Group
Renaissance Technologies
BlackRock
Geode Capital Management
Apella Capital
State Street Corporation
Acadian Asset Management
Rangeley Capital
Royal Bank of Canada
UBS Group
Tower Research Capital
CWM

View all funds holding Minerva Neurosciences